To explore the potential mechanisms by which CSRP2 promotes malignant progression in GBM, we performed GSEA using the CGGA data and found that CSRP2 was positively correlated with the NF-κB signaling pathway (Fig. 4A). This evidence concerns the gene NFKB1 and glioblastoma.